Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M704584200 on July 23, 2007

J. Biol. Chem., Vol. 282, Issue 37, 26857-26864, September 14, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/37/26857    most recent
M704584200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gazzar, M. E.
Right arrow Articles by McCall, C. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gazzar, M. E.
Right arrow Articles by McCall, C. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Epigenetic Silencing of Tumor Necrosis Factor {alpha} during Endotoxin Tolerance*

Mohamed El Gazzar{ddagger}1, Barbara K. Yoza{ddagger}§, Jean Y.-Q. Hu{ddagger}, Sue L. Cousart{ddagger}, and Charles E. McCall{ddagger}

From the {ddagger}Department of Internal Medicine, Section of Molecular Medicine, and§Department of General Surgery, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157

Sustained silencing of potentially autotoxic acute proinflammatory genes like tumor necrosis factor {alpha} (TNF{alpha}) occurs in circulating leukocytes following the early phase of severe systemic inflammation. Aspects of this gene reprogramming suggest the involvement of epigenetic processes. We used THP-1 human promonocytes, which mimic gene silencing when rendered endotoxin-tolerant in vitro, to test whether TNF{alpha} proximal promoter nucleosomes and transcription factors adapt to an activation-specific profile by developing characteristic chromatin-based silencing marks. We found increased TNF{alpha} mRNA levels in endotoxin-responsive cells that was preceded by dissociation of heterochromatin-binding protein 1{alpha}, demethylation of nucleosomal histone H3 lysine 9 (H3(Lys9)), increased phosphorylation of the adjacent serine 10 (H3(Ser10)), and recruitment of NF-{kappa}B RelA/p65 to the TNF{alpha} promoter. In contrast, endotoxintolerant cells repressed production of TNF{alpha} mRNA, retained binding of heterochromatin-binding protein 1{alpha}, sustained methylation of H3(Lys9), reduced phosphorylation of H3(Ser10), and showed diminished binding of NF-{kappa}B RelA/p65 to the TNF{alpha} promoter. Similar levels of NF-{kappa}B p50 occurred at the TNF{alpha} promoter in the basal state, during active transcription, and in the silenced phenotype. RelB, which acts as a repressor of TNF{alpha} transcription, remained bound to the promoter during silencing. These results support an immunodeficiency paradigm where epigenetic changes at the promoter of acute proinflammatory genes mediate their repression during the late phase of severe systemic inflammation.


Received for publication, June 4, 2007 , and in revised form, July 18, 2007.

* This work was supported by National Institutes of Health Grants RO1AI-09169 and RO1AI-065791. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 To whom correspondence should be addressed: Dept. of Internal Medicine, Section of Molecular Medicine, Wake Forest University School of Medicine, Medical Center Blvd., Winston-Salem, NC 27157. Tel.: 336-716-8622; Fax: 336-716-1214; E-mail: melgazza{at}wfubmc.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
M. E. Gazzar, B. K. Yoza, X. Chen, B. A. Garcia, N. L. Young, and C. E. McCall
Chromatin-Specific Remodeling by HMGB1 and Linker Histone H1 Silences Proinflammatory Genes during Endotoxin Tolerance
Mol. Cell. Biol., April 1, 2009; 29(7): 1959 - 1971.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
R. P. Matthews, K. Lorent, R. Manoral-Mobias, Y. Huang, W. Gong, I. V. J. Murray, I. A. Blair, and M. Pack
TNF{alpha}-dependent hepatic steatosis and liver degeneration caused by mutation of zebrafish s-adenosylhomocysteine hydrolase
Development, March 1, 2009; 136(5): 865 - 875.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
X. Chen, B. K. Yoza, M. El Gazzar, J. Y. Q. Hu, S. L. Cousart, and C. E. McCall
RelB Sustains I{kappa}B{alpha} Expression during Endotoxin Tolerance
Clin. Vaccine Immunol., January 1, 2009; 16(1): 104 - 110.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. E. Gazzar, B. K. Yoza, X. Chen, J. Hu, G. A. Hawkins, and C. E. McCall
G9a and HP1 Couple Histone and DNA Methylation to TNF{alpha} Transcription Silencing during Endotoxin Tolerance
J. Biol. Chem., November 21, 2008; 283(47): 32198 - 32208.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. M. Villeneuve, M. A. Reddy, L. L. Lanting, M. Wang, L. Meng, and R. Natarajan
Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes
PNAS, July 1, 2008; 105(26): 9047 - 9052.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Garrett, K. Dietzmann-Maurer, L. Song, and K. E. Sullivan
Polarization of Primary Human Monocytes by IFN-{gamma} Induces Chromatin Changes and Recruits RNA Pol II to the TNF-{alpha} Promoter
J. Immunol., April 15, 2008; 180(8): 5257 - 5266.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement